Sponsor:
University of Florida
Code:
NCT05377424
Conditions
ALS
Eligibility Criteria
Sex: All
Age: 21 - 70+
Healthy Volunteers: Accepted
Interventions
Consume 20mg of istradefylline
Low Oxygen therapy
Placebo counterpart to the istradefylline drug
SHAM counterpart to low oxygen therapy.
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-01. This information was provided to ClinicalTrials.gov by University of Florida on 2024-11-14.